Molecules 2007, 12
1825
7.55 (m, 2H, Harom.); 13C-NMR (δ/ppm): 163.86 (s), 146.46 (s), 143.21 (s), 136.03 (s), 135.93 (d),
132.96 (d), 132.13 (d), 130.56 (s), 125.63 (d), 125.54 (d), 123.93 (d), 122.28 (s), 120.68 (s), 120.24
(d), 116.23 (d), 115.42 (d); MS m/z 262 (M+1); Anal. Calc. for C16H11N3O: C 73.55%, H 4.24%, N
16.08%; found: C 73.81%, H 4.55%, N 16.14%.
2-Carboxamidine-benzimidazo[1,2-a]quinoline-6-carboxamide hydrochloride (8)
Compound 8 was prepared as a yellow powder (0.11 g, yield 43%) using above described Pinner
method from 6 (0.20 g, 0.75 mmol) and NH3 gas; mp >295 °C; IR (KBr) υ/cm-1: 3480, 3220, 1715,
1
1655, 1627, 1589; H-NMR (δ/ppm): 9.92 (s, 1H), 9.60 (brs, 4H, Hamidine), 9.14 (s, 1H), 8.89 (s, 1H),
8.77 (d, 1H, J = 7.60Hz), 8.56 (d, 1H, J = 8.65Hz), 8.20 (s, 1H), 8.11 (d, 1H, J = 7.65Hz), 8.03 (d, 1H,
J = 8.60Hz), 7.72-7.65 (m, 2H); 13C-NMR (δ/ppm): 164.01 (s), 162.11 (s), 146.26 (s), 144.23 (s),
136.33 (d), 136.02 (s), 132.99 (d), 131.01 (s), 129.68 (s), 127.02 (d), 125.89 (s), 125.67 (d), 124.12 (d),
122.56 (s), 120.51 (d), 118.76 (d), 116.28 (d); MS m/z 304 (M+1); Anal. Calc. for C17H14 N5OCl: C
60.09%, H 4.15%, N 20.61%; found: C 60.24%, H 4.33%, N 20.88%.
2-(1H-imidazol-2-yl)-benzimidazo[1,2-a]quinoline-6-carboxamide Hydrochloride (9)
Compound 9 was prepared as a yellow powder (0.180 g, yield 66%) from 6 (0.20 g, 0.75 mmol) and
ethylenediamine (0.121 mL, 1.80 mmol) using above described Pinner method; mp >295 °C; IR (KBr)
υ/cm-1: 3456, 3212, 1730, 1651, 1634, 1593; 1H-NMR (δ/ppm): 11.29 (s, 2H, Hamidine), 9.78 (s, 1H),
9.09 (s, 1H), 9.06 (d, 1H, J = 7.45Hz), 8.87 (s, 1H), 8.44 (d, 1H, J = 8.40Hz), 8.37 (s, 1H), 8.20 (d, 1H,
J = 8.37Hz), 8.06 (d, 1H, J = 7.50Hz), 7.71-7.64 (m, 2H), 4.11 (brs, 2H, CH2), 3.09 (brs, 2H, CH2); 13C
NMR (δ/ppm): 163.98 (s), 162.14 (s), 145.96 (s), 144.40 (s), 136.88 (s), 136.34 (d), 133.10 (d), 131.33
(s), 129.61 (s), 127.41 (d), 126.10 (s), 125.89 (d), 124.24 (d), 122.44 (s), 120.58 (d), 118.76 (d), 116.02
(d), 46.45 (t), 39.88 (t); MS m/z 330 (M+); Anal. Calc. for C19H16N5OCl: C 62.38%, H 4.41%,
N19.14%; found: C 62.54%, H 4.26%, N 18.89%.
N-Morpholin-4-yl-benzimidazo[1,2-a]quinoline-6-carboxamide hydrochloride (10)
Compound 10 was prepared as a yellow powder (0.20 g, yield 63 %) from 6 (0.20 g, 0.75 mmol)
and 4-aminomorpholine (0.360 mL, 1.80 mmol) using above described Pinner method; mp >295 °C;
IR (KBr) υ/cm-1: 3480, 3256, 1726, 1639, 1624, 1591; 1H-NMR (δ/ppm): 11.63 (s, 1H, Hamidine), 10.20
(s, 1H, Hamidine), 9.82 (s, 1H), 9.45 (s, 1H, Hamidine), 9.08 (s, 1H), 8.92 (d, 1H, J = 7.10Hz), 8.86 (s, 1H),
8.54 (d, 1H, J = 8.16Hz), 8.32 (s, 1H), 8.10 (d, 1H, J = 7.11Hz), 7.98 (d, 1H, J = 8.25Hz), 7.69-7.64
(m, 2H), 3.83 (brs, 4H, 2CH2), 3.20 (brs, 2H, 2CH2); 13C-NMR (δ/ppm): 163.54 (s), 161.84 (s), 145.87
(s), 144.08 (s), 135.10 (s), 135.03 (d), 132.36 (d), 130.23 (s), 129.63 (s), 126.31 (d), 125.76 (s), 125.20
(d), 124.53 (d), 122.75 (s), 120.08 (d), 116.55 (d), 116.13 (d), 66.01 (t, 2C), 54.42 (t, 2C); MS m/z 389
(M+1); Anal. Calc. for C21H21N6O2Cl: C 59.36%, H 4.98%, N 19.78%; found: C 59.56%, H 5.11%, N
20.03%.